This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

William Fang
Vice President of Oligonucleotide and Peptide Development at WuXi TIDES
Speaker

Profile

William Fang is the Vice President, Head of the Oligo/Peptide Development at WuXi TIDES. He has held various roles for over ten years with WuXi AppTec and has extensive experience in peptide R&D and manufacturing. Previously he worked at Zhejiang Runxin Pharmtech and Polypeptide labs. William received his bachelor’s degree from Beijing Medical University, his Master’s degree from Creighton

Agenda Sessions

  • Bridging the Translational Chasm in Oligonucleotide/Peptide Programs: A Convergence Framework in Propelling Novel Modalities from Lead Optimization to GMP Readiness

    13:25